These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Endocrine profile in gastric carcinomas. An immunohistochemical study. Berner A; Nesland JM Histol Histopathol; 1991 Jul; 6(3):317-23. PubMed ID: 1725759 [TBL] [Abstract][Full Text] [Related]
9. [Neuroendocrine carcinoma of the esophagus. Case report with immunohistochemical study]. Le Berre N; Le Gall F; Maddern G; Beurton D; Launois B; Ramee MP Ann Pathol; 1992; 12(6):358-61. PubMed ID: 1294157 [TBL] [Abstract][Full Text] [Related]
10. Sinonasal adenocarcinoma: immunohistochemical marking and expression of oncoproteins. Bashir AA; Robinson RA; Benda JA; Smith RB Head Neck; 2003 Sep; 25(9):763-71. PubMed ID: 12953313 [TBL] [Abstract][Full Text] [Related]
11. Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases. Matsui K; Kitagawa M; Miwa A; Kuroda Y; Tsuji M Am J Gastroenterol; 1991 Sep; 86(9):1167-75. PubMed ID: 1715667 [TBL] [Abstract][Full Text] [Related]
12. The Role of SATB2 as a Diagnostic Marker of Sinonasal Intestinal-type Adenocarcinoma. Skalova A; Sar A; Laco J; Metelkova A; Miesbauerova M; Steiner P; Švajdler M; Michal M Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):140-146. PubMed ID: 27258560 [TBL] [Abstract][Full Text] [Related]
13. [Pheochromocytoma--pathohistologic and immunohistochemical aspects]. Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus. Goto K; Kodama T; Matsuno Y; Yokose T; Asamura H; Kamiya N; Shimosato Y Mod Pathol; 2001 Oct; 14(10):985-94. PubMed ID: 11598168 [TBL] [Abstract][Full Text] [Related]
15. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Friedman MT; Gentile P; Tarectecan A; Fuchs A Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma. Hamilton K; Chiappori A; Olson S; Sawyers J; Johnson D; Washington K Mod Pathol; 2000 May; 13(5):475-81. PubMed ID: 10824917 [TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine carcinoma of the colon and rectum. A clinicopathologic, ultrastructural, and immunohistochemical study of 24 cases. Gaffey MJ; Mills SE; Lack EE Am J Surg Pathol; 1990 Nov; 14(11):1010-23. PubMed ID: 2173427 [TBL] [Abstract][Full Text] [Related]
19. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum. Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522 [TBL] [Abstract][Full Text] [Related]